20 Oct 2025Open access
The CAIRO Journal Club: A Decade of ImpactPublisher siteJournal of Cancer Education, Advances in Oncology and Radiotherapy
Active, last published 2026
In global cancer incidence and screening
A.H.
Abdelaziz
Scholar“Research focused on Global Cancer Incidence and Screening and adjacent fields.”
Claim Your Profile4
H-index
125
Citations
A.H. has not officially claimed their profile. If you are A.H., claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
.H. Abdelaziz is a researcher working on Global Cancer Incidence and Screening. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
A.H.'s work has been cited 125 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Global Cancer Incidence and Screening×7Economic and Financial Impacts of Cancer×3Breast Cancer Treatment Studies×3Cancer Genomics and Diagnostics×3HER2/EGFR in Cancer Research×2
04 · Where I am
Affiliations
Affiliation on published researchAin Shams University Hospital, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
6 works1 Sept 2025
2315P Governmental pharma-industry partnership transforms Egypt’s breast cancer patient journey: Data from the National Breast Cancer Program (2019–2024)Publisher siteAnnals of Oncology, Economic and Financial Impacts of Cancer
1 Sept 2025
2321P Hospital time impact of subcutaneous vs intravenous anti-HER2 therapies in Egypt: A time-motion studyPublisher siteAnnals of Oncology, Safe Handling of Antineoplastic Drugs
12 Dec 2024Open access1cites
The cost-effectiveness of treatment for high-risk, early-stage, triple-negative breast cancer in Egypt: an analysis of neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant single-agent pembrolizumabPublisher siteJournal of Medical Economics, Cancer Immunotherapy and Biomarkers
1 Oct 2024Open access
The Impact of the HER2 Status(HER2 Low vs HER2 Negative) on the Pathological Response to Neoadjuvant Chemotherapy in Hormonal Receptor Positive Breast CancerPublisher siteQJM, HER2/EGFR in Cancer Research
1 Sept 2024Open access
1558P Independent validation of the Breast Cancer Risk Assessment Tool (Gail model) for predicting breast cancer risk in Egyptian populationPublisher siteAnnals of Oncology, Global Cancer Incidence and Screening
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you A.H.?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you